In this study, we found that the mRNA expression levels of IDO1 were higher than those of TMIGD2 in nearly all patients, indicating that both the activation of inhibitory immune pathways and the weakening of stimulatory pathways promote tumor immune evasion. This evidence concerns the gene TMIGD2 and neoplasm.